The coming of age of DNA-based catalysts for therapeutic applications
Robert Hesse
Faculty of Mathematics and Natural Sciences, Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University, Düsseldorf, Germany
Search for more papers by this authorChristoph G. W. Gertzen
Faculty of Mathematics and Natural Sciences, Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University, Düsseldorf, Germany
Faculty of Mathematics and Natural Sciences, Center for Structural Studies, Heinrich Heine University, Düsseldorf, Germany
Search for more papers by this authorJessica Felice Schmuck
Faculty of Mathematics and Natural Sciences, Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany
Search for more papers by this authorJustin Darvin Böcker
Faculty of Mathematics and Natural Sciences, Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany
Search for more papers by this authorPiyush Pandey
Department of Molecular Medicine II, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
Search for more papers by this authorTobias Behn
Department of Chemistry, Institute of Organic Chemistry, University of Cologne, Cologne, Germany
Search for more papers by this authorChristopher Ruth
Faculty of Mathematics and Natural Sciences, Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany
Search for more papers by this authorDetlev Riesner
Faculty of Mathematics and Natural Sciences, Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany
Search for more papers by this authorCorresponding Author
Stephanie Kath-Schorr
Department of Chemistry, Institute of Organic Chemistry, University of Cologne, Cologne, Germany
Correspondence
Stephanie Kath-Schorr, Department of Chemistry, Institute of Organic Chemistry, University of Cologne, Cologne, Germany.
Email: [email protected]
Philipp Lang, Department of Molecular Medicine II, University Hospital Düsseldorf, Dusseldorf, Germany.
Email: [email protected]
Holger Gohlke, Faculty of Mathematics and Natural Sciences, Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University, Düsseldorf, Germany.
Email: [email protected]
Manuel Etzkorn, Faculty of Mathematics and Natural Sciences, Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany.
Email: [email protected]
Search for more papers by this authorCorresponding Author
Philipp A. Lang
Department of Molecular Medicine II, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
Correspondence
Stephanie Kath-Schorr, Department of Chemistry, Institute of Organic Chemistry, University of Cologne, Cologne, Germany.
Email: [email protected]
Philipp Lang, Department of Molecular Medicine II, University Hospital Düsseldorf, Dusseldorf, Germany.
Email: [email protected]
Holger Gohlke, Faculty of Mathematics and Natural Sciences, Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University, Düsseldorf, Germany.
Email: [email protected]
Manuel Etzkorn, Faculty of Mathematics and Natural Sciences, Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany.
Email: [email protected]
Search for more papers by this authorCorresponding Author
Holger Gohlke
Faculty of Mathematics and Natural Sciences, Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University, Düsseldorf, Germany
Institute of Bio- and Geosciences (IBG-4: Bioinformatics), Forschungszentrum Jülich, Jülich, Germany
Correspondence
Stephanie Kath-Schorr, Department of Chemistry, Institute of Organic Chemistry, University of Cologne, Cologne, Germany.
Email: [email protected]
Philipp Lang, Department of Molecular Medicine II, University Hospital Düsseldorf, Dusseldorf, Germany.
Email: [email protected]
Holger Gohlke, Faculty of Mathematics and Natural Sciences, Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University, Düsseldorf, Germany.
Email: [email protected]
Manuel Etzkorn, Faculty of Mathematics and Natural Sciences, Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany.
Email: [email protected]
Search for more papers by this authorCorresponding Author
Manuel Etzkorn
Faculty of Mathematics and Natural Sciences, Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany
Institute of Biological Information Processing (IBI-7), Forschungszentrum Jülich, Jülich, Germany
Correspondence
Stephanie Kath-Schorr, Department of Chemistry, Institute of Organic Chemistry, University of Cologne, Cologne, Germany.
Email: [email protected]
Philipp Lang, Department of Molecular Medicine II, University Hospital Düsseldorf, Dusseldorf, Germany.
Email: [email protected]
Holger Gohlke, Faculty of Mathematics and Natural Sciences, Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University, Düsseldorf, Germany.
Email: [email protected]
Manuel Etzkorn, Faculty of Mathematics and Natural Sciences, Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany.
Email: [email protected]
Search for more papers by this authorRobert Hesse
Faculty of Mathematics and Natural Sciences, Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University, Düsseldorf, Germany
Search for more papers by this authorChristoph G. W. Gertzen
Faculty of Mathematics and Natural Sciences, Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University, Düsseldorf, Germany
Faculty of Mathematics and Natural Sciences, Center for Structural Studies, Heinrich Heine University, Düsseldorf, Germany
Search for more papers by this authorJessica Felice Schmuck
Faculty of Mathematics and Natural Sciences, Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany
Search for more papers by this authorJustin Darvin Böcker
Faculty of Mathematics and Natural Sciences, Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany
Search for more papers by this authorPiyush Pandey
Department of Molecular Medicine II, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
Search for more papers by this authorTobias Behn
Department of Chemistry, Institute of Organic Chemistry, University of Cologne, Cologne, Germany
Search for more papers by this authorChristopher Ruth
Faculty of Mathematics and Natural Sciences, Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany
Search for more papers by this authorDetlev Riesner
Faculty of Mathematics and Natural Sciences, Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany
Search for more papers by this authorCorresponding Author
Stephanie Kath-Schorr
Department of Chemistry, Institute of Organic Chemistry, University of Cologne, Cologne, Germany
Correspondence
Stephanie Kath-Schorr, Department of Chemistry, Institute of Organic Chemistry, University of Cologne, Cologne, Germany.
Email: [email protected]
Philipp Lang, Department of Molecular Medicine II, University Hospital Düsseldorf, Dusseldorf, Germany.
Email: [email protected]
Holger Gohlke, Faculty of Mathematics and Natural Sciences, Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University, Düsseldorf, Germany.
Email: [email protected]
Manuel Etzkorn, Faculty of Mathematics and Natural Sciences, Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany.
Email: [email protected]
Search for more papers by this authorCorresponding Author
Philipp A. Lang
Department of Molecular Medicine II, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
Correspondence
Stephanie Kath-Schorr, Department of Chemistry, Institute of Organic Chemistry, University of Cologne, Cologne, Germany.
Email: [email protected]
Philipp Lang, Department of Molecular Medicine II, University Hospital Düsseldorf, Dusseldorf, Germany.
Email: [email protected]
Holger Gohlke, Faculty of Mathematics and Natural Sciences, Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University, Düsseldorf, Germany.
Email: [email protected]
Manuel Etzkorn, Faculty of Mathematics and Natural Sciences, Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany.
Email: [email protected]
Search for more papers by this authorCorresponding Author
Holger Gohlke
Faculty of Mathematics and Natural Sciences, Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University, Düsseldorf, Germany
Institute of Bio- and Geosciences (IBG-4: Bioinformatics), Forschungszentrum Jülich, Jülich, Germany
Correspondence
Stephanie Kath-Schorr, Department of Chemistry, Institute of Organic Chemistry, University of Cologne, Cologne, Germany.
Email: [email protected]
Philipp Lang, Department of Molecular Medicine II, University Hospital Düsseldorf, Dusseldorf, Germany.
Email: [email protected]
Holger Gohlke, Faculty of Mathematics and Natural Sciences, Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University, Düsseldorf, Germany.
Email: [email protected]
Manuel Etzkorn, Faculty of Mathematics and Natural Sciences, Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany.
Email: [email protected]
Search for more papers by this authorCorresponding Author
Manuel Etzkorn
Faculty of Mathematics and Natural Sciences, Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany
Institute of Biological Information Processing (IBI-7), Forschungszentrum Jülich, Jülich, Germany
Correspondence
Stephanie Kath-Schorr, Department of Chemistry, Institute of Organic Chemistry, University of Cologne, Cologne, Germany.
Email: [email protected]
Philipp Lang, Department of Molecular Medicine II, University Hospital Düsseldorf, Dusseldorf, Germany.
Email: [email protected]
Holger Gohlke, Faculty of Mathematics and Natural Sciences, Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University, Düsseldorf, Germany.
Email: [email protected]
Manuel Etzkorn, Faculty of Mathematics and Natural Sciences, Institute of Physical Biology, Heinrich Heine University, Düsseldorf, Germany.
Email: [email protected]
Search for more papers by this author
CONFLICT OF INTEREST STATEMENT
The authors declare no conflicts of interest.
Supporting Information
| Filename | Description |
|---|---|
| ctm270408-sup-0001-SuppMat.pdf7.8 MB | Supporting information |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Breaker RR, Joyce GF. A DNA enzyme that cleaves RNA. Chem Biol. 1994; 1: 223-229.
- 2Santoro SW, Joyce GF. A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci. 1997; 94: 4262-4266.
- 3Rabani M, Levin JZ, Fan L, et al. Metabolic labeling of RNA uncovers principles of RNA production and degradation dynamics in mammalian cells. Nat Biotechnol. 2011; 29: 436-442.
- 4Borggräfe J, Victor J, Rosenbach H, et al. Time-resolved structural analysis of an RNA-cleaving DNA catalyst. Nature. 2022; 601: 144-149.
- 5Krug N, Hohlfeld JM, Kirsten A, et al. Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme. New Engl J Med. 2015; 372: 1987-1995.
- 6Popp V, Gerlach K, Mott S, et al. Rectal delivery of a DNAzyme that specifically blocks the transcription factor GATA3 and reduces colitis in mice. Gastroenterology. 2017; 152: 176-192.
- 7Cao Y, Yang L, Jiang W, et al. Therapeutic evaluation of epstein-barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomas. Mol Ther. 2014; 22: 371-377.
- 8Cho E, Moloney FJ, Cai H, et al. Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER). Lancet. 2013; 381: 1835-1843.
- 9Zhang Z, Zhang S, Wang S. DNAzymes Dz13 target the c-jun possess antiviral activity against influenza A viruses. Microb Pathog. 2017; 103: 155-161.
- 10Appaiahgari MB, Vrati S. DNAzyme-mediated inhibition of Japanese encephalitis virus replication in mouse brain. Mol Ther. 2007; 15: 1593-1599.
- 11Potaczek DP, Unger SD, Zhang N, et al. Development and characterization of DNAzyme candidates demonstrating significant efficiency against human rhinoviruses. J Allergy Clin Immunol. 2019; 143: 1403-1415.
- 12Xie Y, Zhao X, Jiang L, et al. Inhibition of respiratory syncytial virus in cultured cells by nucleocapsid gene targeted deoxyribozyme (DNAzyme). Antiviral Res. 2006; 71: 31-41.
- 13Gerber PP, Donde MJ, Matheson NJ, Taylor AI. XNAzymes targeting the SARS-CoV-2 genome inhibit viral infection. Nat Commun. 2022; 13: 6716.
- 14Victor J, Steger G, Riesner D. Inability of DNAzymes to cleave RNA in vivo is due to limited Mg2+ concentration in cells. Eur Biophys J. 2018; 47: 333-343.
- 15Silverman SK. Catalytic DNA: scope, applications, and biochemistry of deoxyribozymes. Trends Biochem Sci. 2016; 41: 595-609.
- 16Rosenbach H, Victor J, Etzkorn M, Steger G, Riesner D, Span I. Molecular features and metal ions that influence 10–23 DNAzyme activity. Molecules. 2020; 25: 3100.
- 17Rosenbach H, Borggräfe J, Victor J, et al. Influence of monovalent metal ions on metal binding and catalytic activity of the 10–23 DNAzyme. Biol Chem. 2020; 402: 99-111.
- 18Okumoto Y, Sugimoto N. Effects of metal ions and catalytic loop sequences on the complex formation of a deoxyribozyme and its RNA substrate. J Inorg Biochem. 2000; 82: 189-195.
- 19Yan J, Ran M, Shen X, Zhang H. Therapeutic DNAzymes: from structure design to clinical applications. Adv Mater. 2023; 35:2300374.
- 20Nguyen K, Malik TN, Chaput JC. Chemical evolution of an autonomous DNAzyme with allele-specific gene silencing activity. Nat Commun. 2023; 14: 2413.
- 21Dhuri K, Bechtold C, Quijano E, et al. Antisense oligonucleotides: an emerging area in drug discovery and development. J Clin Med. 2020; 9: 2004.
- 22Wang R, He W, Yi X, Wu Z, Chu X, Jiang J. Site-specific bioorthogonal activation of DNAzymes for on-demand gene therapy. J Am Chem Soc. 2023; 145: 17926-17935.
- 23Wang Y, Nguyen K, Spitale RC, Chaput JC. A biologically stable DNAzyme that efficiently silences gene expression in cells. Nat Chem. 2021; 13: 319-326.
- 24Taylor AI, Wan CJK, Donde MJ, Peak-Chew S, Holliger P. A modular XNAzyme cleaves long, structured RNAs under physiological conditions and enables allele-specific gene silencing. Nat Chem. 2022; 14: 1295-1305.
- 25Nguyen K, Wang Y, England WE, Chaput JC, Spitale RC. Allele-specific RNA knockdown with a biologically stable and catalytically efficient XNAzyme. J Am Chem Soc. 2021; 143: 4519-4523.
- 26Gerber PP, Donde MJ, Matheson NJ, Taylor AI. XNAzymes targeting the SARS-CoV-2 genome inhibit viral infection. Nat Commun. 2022; 13: 6716.
- 27Freund N, Taylor AI, Arangundy-Franklin S, et al. A two-residue nascent-strand steric gate controls synthesis of 2′-O-methyl- and 2′-O-(2-methoxyethyl)-RNA. Nat Chem. 2023; 15: 91-100.
- 28Borggräfe J, Gertzen CGW, Viegas A, Gohlke H, Etzkorn M. The architecture of the 10-23 DNAzyme and its implications for DNA-mediated catalysis. FEBS J. 2023; 290: 2011-2021.
- 29Wieruszewska J, Pawłowicz A, Połomska E, Pasternak K, Gdaniec Z, Andrałojć W. The 8–17 DNAzyme can operate in a single active structure regardless of metal ion cofactor. Nat Commun. 2024; 15: 4218.
- 30Huang PJ, Liu J. In vitro selection of chemically modified DNAzymes. Chem Open. 2020; 9: 1046-1059.
- 31Liu H, Yu X, Chen Y, et al. Crystal structure of an RNA-cleaving DNAzyme. Nat Commun. 2017; 8: 2006.
- 32Sednev MV, Liaqat A, Höbartner C. High-throughput activity profiling of RNA-cleaving DNA catalysts by deoxyribozyme sequencing (DZ-seq). J Am Chem Soc. 2022; 144: 2090-2094.
